| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Docosahexaenoic Acid | ADHD | 1 | PM | 35960396 | 📋 | Red blood cell omega-3 fatty acids and attention scores in healthy adolescents |
| Docosahexaenoic Acid | Age-Related Cognitive Decline | 5 | PM | 35866081 | 📋 | A Dietary Supplement Containing Micronutrients, Phosphatidylserine, and Docosahexaenoic Acid Counteracts Cognitive Impairment in D-Galactose-Induced Aged Rats |
| Docosahexaenoic Acid | Age-Related Cognitive Decline | 4 | PM | 35704085 | 📋 | DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial |
| Docosahexaenoic Acid | Age-Related Cognitive Decline | 3 | PM | 35618634 | 📋 | Docosahexaenoic acid enhances hippocampal insulin sensitivity to promote cognitive function of aged rats on a high-fat diet |
| Docosahexaenoic Acid | Age-Related Cognitive Decline | 1 | PM | 32856190 | 📋 | Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial |
| Docosahexaenoic Acid | Age-Related Cognitive Decline | 2 | PM | 26901223 | 📋 | Docosahexaenoic Acid and Cognition throughout the Lifespan |
| Docosahexaenoic Acid | Alzheimer's Disease | 18 | PM | 38373507 | 📋 | N-3 polyunsaturated fatty acids attenuate amyloid-beta-induced toxicity in AD transgenic Caenorhabditis elegans via promotion of proteasomal activity and activation of PPAR-gamma |
| Docosahexaenoic Acid | Alzheimer's Disease | 17 | PM | 37836528 | 📋 | Supplementation of Medium-Chain Triglycerides Combined with Docosahexaenoic Acid Inhibits Amyloid Beta Protein Deposition by Improving Brain Glucose Metabolism in APP/PS1 Mice |
| Docosahexaenoic Acid | Alzheimer's Disease | 16 | PM | 36678710 | 📋 | Docosahexaenoic Acid Ameliorates Contextual Fear Memory Deficits in the Tg2576 Alzheimer's Disease Mouse Model: Cellular and Molecular Correlates |
| Docosahexaenoic Acid | Alzheimer's Disease | 15 | PM | 35782939 | 📋 | DHA Ameliorates Cognitive Ability, Reduces Amyloid Deposition, and Nerve Fiber Production in Alzheimer's Disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 14 | PM | 35334816 | 📋 | Higher Serum DHA and Slower Cognitive Decline in Patients with Alzheimer's Disease: Two-Year Follow-Up |
| Docosahexaenoic Acid | Alzheimer's Disease | 13 | PM | 35250535 | 📋 | A Synergistic Combination of DHA, Luteolin, and Urolithin A Against Alzheimer's Disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 12 | PM | 34769257 | 📋 | Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer's Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue |
| Docosahexaenoic Acid | Alzheimer's Disease | 11 | PM | 34205196 | 📋 | DHA and Its Elaborated Modulation of Antioxidant Defenses of the Brain: Implications in Aging and AD Neurodegeneration |
| Docosahexaenoic Acid | Alzheimer's Disease | 10 | PM | 34182090 | 📋 | Combination of docosahexaenoic acid and Ginko biloba extract improves cognitive function and hippocampal tissue damages in a mouse model of Alzheimer's disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 9 | PM | 33733657 | 📋 | DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 4 | PM | 33163896 | 📋 | Effects of a Nutritional Formulation Containing Caprylic and Capric Acid, Phosphatidylserine, and Docosahexaenoic Acid in Streptozotocin-Lesioned Rats |
| Docosahexaenoic Acid | Alzheimer's Disease | 3 | PM | 32806612 | 📋 | Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment? |
| Docosahexaenoic Acid | Alzheimer's Disease | 2 | PM | 32486013 | 📋 | Omega-3 Fatty Acid-Type Docosahexaenoic Acid Protects Against Aβ-Mediated Mitochondrial Deficits and Pathomechanisms in Alzheimer's Disease-Related Animal Model |
| Docosahexaenoic Acid | Alzheimer's Disease | 1 | PM | 29695154 | 📋 | Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice |
| Docosahexaenoic Acid | Alzheimer's Disease | 8 | PM | 27825512 | 📋 | The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 6 | PM | 27532692 | 📋 | Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis |
| Docosahexaenoic Acid | Alzheimer's Disease | 5 | PM | 26606074 | 📋 | Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease |
| Docosahexaenoic Acid | Alzheimer's Disease | 7 | PM | 19686246 | 📋 | Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells |
| Docosahexaenoic Acid | Anorexia Nervosa | 1 | PM | 17311056 | 📋 | Breastfeeding's protection against illness-induced anorexia is mediated partially by docosahexaenoic acid |
| Docosahexaenoic Acid | Autism Spectrum Disorder | 2 | PM | 30744880 | 📋 | A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder |
| Docosahexaenoic Acid | Autism Spectrum Disorder | 1 | PM | 30607782 | 📋 | A Randomised-Controlled Trial of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids in the Treatment of Core Symptoms of Autism Spectrum Disorder in Children |
| Docosahexaenoic Acid | Autism Spectrum Disorder | 6 | PM | 29288796 | 📋 | DHA Mitigates Autistic Behaviors Accompanied by Dopaminergic Change in a Gene/Prenatal Stress Mouse Model |
| Docosahexaenoic Acid | Autism Spectrum Disorder | 3 | PM | 26746679 | 📋 | Abnormal fatty acids in Canadian children with autism |
| Docosahexaenoic Acid | Autism Spectrum Disorder | 5 | PM | 19307110 | 📋 | Plasma fatty acid profiles in autism: a case-control study |
| Docosahexaenoic Acid | Autism Spectrum Disorder | 4 | PM | 16978397 | 📋 | Breastfeeding, infant formula supplementation, and Autistic Disorder: the results of a parent survey |
| Docosahexaenoic Acid | Bipolar Disorder | 1 | PM | 26486098 | 📋 | Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker |
| Docosahexaenoic Acid | Bipolar Disorder | 2 | PM | 18715653 | 📋 | Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder |
| Docosahexaenoic Acid | Cognitive Disorders | 3 | PM | 37890592 | 📋 | Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE |
| Docosahexaenoic Acid | Cognitive Disorders | 9 | PM | 35565665 | 📋 | DHA-Enriched Fish Oil Ameliorates Deficits in Cognition Associated with Menopause and the APOE4 Genotype in Rodents |
| Docosahexaenoic Acid | Cognitive Disorders | 8 | PM | 35334816 | 📋 | Higher Serum DHA and Slower Cognitive Decline in Patients with Alzheimer's Disease: Two-Year Follow-Up |
| Docosahexaenoic Acid | Cognitive Disorders | 7 | PM | 34934425 | 📋 | Docosahexaenoic acid supplementation alleviates behavioral memory impairment caused via repeated administration of sevoflurane in aged rats |
| Docosahexaenoic Acid | Cognitive Disorders | 6 | PM | 34676845 | 📋 | Protective effect and mechanism of docosahexaenoic acid on the cognitive function in female APP/PS1 mice |
| Docosahexaenoic Acid | Cognitive Disorders | 2 | PM | 32840165 | 📋 | Cognitive improvements in a rat model with polyunsaturated fatty acids EPA and DHA through α7-nicotinic acetylcholine receptors |
| Docosahexaenoic Acid | Cognitive Disorders | 5 | PM | 26901223 | 📋 | Docosahexaenoic Acid and Cognition throughout the Lifespan |
| Docosahexaenoic Acid | Cognitive Disorders | 1 | PM | 25550171 | 📋 | Curcumin Boosts DHA in the Brain: Implications for the Prevention of Anxiety Disorders |
| Docosahexaenoic Acid | Cognitive Disorders | 4 | PM | 22254110 | 📋 | Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain |
| Docosahexaenoic Acid | Dementia | 2 | PM | 34759112 | 📋 | Intake of Docosahexaenoic Acid-Enriched Milk Beverage Prevents Age-Related Cognitive Decline and Decreases Serum Bone Resorption Marker Levels |
| Docosahexaenoic Acid | Dementia | 1 | PM | 32316172 | 📋 | Green Nut Oil or DHA Supplementation Restored Decreased Distribution Levels of DHA Containing Phosphatidylcholines in the Brain of a Mouse Model of Dementia |
| Docosahexaenoic Acid | Depression | 2 | PM | 38136199 | 📋 | DHA and EPA Alleviate Epileptic Depression in PTZ-Treated Young Mice Model by Inhibiting Neuroinflammation through Regulating Microglial M2 Polarization and Improving Mitochondrial Metabolism |
| Docosahexaenoic Acid | Depression | 1 | PM | 26300645 | 📋 | Combined application of eicosapentaenoic acid and docosahexaenoic acid on depression in women: a meta-analysis of double-blind randomized controlled trials |
| Docosahexaenoic Acid | Depression | 5 | PM | 18707812 | 📋 | Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats |
| Docosahexaenoic Acid | Dyslexia | 1 | PM | 18158838 | 📋 | A 5-month open study with long-chain polyunsaturated fatty acids in dyslexia |
| Docosahexaenoic Acid | Mild Cognitive Impairment | 2 | PM | 33749643 | 📋 | Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-β-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind, Placebo-Controlled Trial |
| Docosahexaenoic Acid | Mild Cognitive Impairment | 1 | PM | 26757190 | 📋 | Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment |
| Docosahexaenoic Acid | Postpartum Depression | 4 | PM | 18707812 | 📋 | Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats |
| Docosahexaenoic Acid | Postpartum Depression | 5 | PM | 17182813 | 📋 | Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet |
| Docosahexaenoic Acid | Postpartum Depression | 3 | PM | 16499882 | 📋 | Reduced brain DHA content after a single reproductive cycle in female rats fed a diet deficient in N-3 polyunsaturated fatty acids |
| Docosahexaenoic Acid | Postpartum Depression | 2 | PM | 12907133 | 📋 | Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status |
| Docosahexaenoic Acid | Postpartum Depression | 1 | PM | 12103448 | 📋 | Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis |
